Implantation-Related Complications of Implantable Cardioverter-Defibrillators and Cardiac Resynchronization Therapy Devices: A Systematic Review of Randomized Clinical Trials

The number of implantable cardioverter-defibrillator (ICD) and cardiac resynchronization therapy (CRT) implantations is increasing drastically worldwide, and hence, the number of implanting centers is also increasing. Despite abundant data on the beneficial effect of these devices, little is known r...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of the American College of Cardiology 2011-08, Vol.58 (10), p.995-1000
Hauptverfasser: VAN REES, Johannes B, DE BIE, Mihaly K, THIJSSEN, Joep, BORLEFFS, C. Jan Willem, SCHALIJ, Martin J, ERVEN, Lieselot Van
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1000
container_issue 10
container_start_page 995
container_title Journal of the American College of Cardiology
container_volume 58
creator VAN REES, Johannes B
DE BIE, Mihaly K
THIJSSEN, Joep
BORLEFFS, C. Jan Willem
SCHALIJ, Martin J
ERVEN, Lieselot Van
description The number of implantable cardioverter-defibrillator (ICD) and cardiac resynchronization therapy (CRT) implantations is increasing drastically worldwide, and hence, the number of implanting centers is also increasing. Despite abundant data on the beneficial effect of these devices, little is known regarding safety and complication rates. Eleven ICD and 7 CRT trials were systematically reviewed to provide data on the frequency of in-hospital mortality and complications related to the implantation. Average in-hospital mortality was 2.7% in trials using both thoracotomy and nonthoracotomy ICDs, 0.2% in trials using nonthoracotomy ICDs, and 0.3% in CRT trials. The pneumothorax rate was similar between the nonthoracotomy ICD and CRT trials (0.9%) Coronary sinus complications occurred in 2.0% of patients undergoing CRT. Lead dislodgement rates were higher in CRT trials (5.7%) than in nonthoracotomy ICD trials (1.8%).
doi_str_mv 10.1016/j.jacc.2011.06.007
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_885564525</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>3389146021</sourcerecordid><originalsourceid>FETCH-LOGICAL-p301t-42955c2fa648aeda2ce99fcb463c0bfad4c61317dc4bf845966da5d7cf3e5dbb3</originalsourceid><addsrcrecordid>eNp90c1q3DAQAGBRGppt2hfooQhKaS92JVmSpdzCpj-BQGC7PRtZGhMttuVK3i2bh-ozVptsKOSQ08DMp9GMhNA7SkpKqPyyKTfG2pIRSksiS0LqF2hBhVBFJXT9Ei1IXYmCEl2fotcpbQghUlH9Cp0yqmStKrZAf6-GqTfjbGYfxmIFvZnB4WXIWW_vkwmHDj-qtge8NNH5sIM4QywuofNt9H0-F2LCZnQPdWPxCtJ-tLcxjP7uvhNe30I00x5fws5bSOf4Av_cpxmGXD74nYc_h9tWuU0Y_N1hkt6PeZAer6M3fXqDTroc4O0xnqFf376ulz-K65vvV8uL62KqCJ0LzrQQlnVGcmXAGWZB6862XFaWtJ1x3Epa0dpZ3naKCy2lM8LVtqtAuLatztCnh75TDL-3kOZm8MlCXnOEsE2NUkJILpjI8vOzkipKs-ZCZfrhCd2EbRzzHg0VXGslNGVZvT-qbTuAa6boBxP3zeOfZfDxCEzKL9NFM1qf_jvOa1YLVv0DRBCrFA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1549985912</pqid></control><display><type>article</type><title>Implantation-Related Complications of Implantable Cardioverter-Defibrillators and Cardiac Resynchronization Therapy Devices: A Systematic Review of Randomized Clinical Trials</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><source>EZB-FREE-00999 freely available EZB journals</source><source>Alma/SFX Local Collection</source><creator>VAN REES, Johannes B ; DE BIE, Mihaly K ; THIJSSEN, Joep ; BORLEFFS, C. Jan Willem ; SCHALIJ, Martin J ; ERVEN, Lieselot Van</creator><creatorcontrib>VAN REES, Johannes B ; DE BIE, Mihaly K ; THIJSSEN, Joep ; BORLEFFS, C. Jan Willem ; SCHALIJ, Martin J ; ERVEN, Lieselot Van</creatorcontrib><description>The number of implantable cardioverter-defibrillator (ICD) and cardiac resynchronization therapy (CRT) implantations is increasing drastically worldwide, and hence, the number of implanting centers is also increasing. Despite abundant data on the beneficial effect of these devices, little is known regarding safety and complication rates. Eleven ICD and 7 CRT trials were systematically reviewed to provide data on the frequency of in-hospital mortality and complications related to the implantation. Average in-hospital mortality was 2.7% in trials using both thoracotomy and nonthoracotomy ICDs, 0.2% in trials using nonthoracotomy ICDs, and 0.3% in CRT trials. The pneumothorax rate was similar between the nonthoracotomy ICD and CRT trials (0.9%) Coronary sinus complications occurred in 2.0% of patients undergoing CRT. Lead dislodgement rates were higher in CRT trials (5.7%) than in nonthoracotomy ICD trials (1.8%).</description><identifier>ISSN: 0735-1097</identifier><identifier>EISSN: 1558-3597</identifier><identifier>DOI: 10.1016/j.jacc.2011.06.007</identifier><identifier>PMID: 21867832</identifier><identifier>CODEN: JACCDI</identifier><language>eng</language><publisher>New York, NY: Elsevier</publisher><subject>Biological and medical sciences ; Cardiac Resynchronization Therapy Devices ; Cardiology ; Cardiology. Vascular system ; Clinical trials ; Defibrillators, Implantable ; Dissection ; Heart attacks ; Hospitals ; Humans ; Medical sciences ; Medicare ; Mortality ; Ostomy ; Postoperative Complications - epidemiology ; Prosthesis Implantation - adverse effects ; Prosthesis Implantation - mortality ; Radiotherapy. Instrumental treatment. Physiotherapy. Reeducation. Rehabilitation, orthophony, crenotherapy. Diet therapy and various other treatments (general aspects) ; Randomized Controlled Trials as Topic ; Studies ; Veins &amp; arteries</subject><ispartof>Journal of the American College of Cardiology, 2011-08, Vol.58 (10), p.995-1000</ispartof><rights>2015 INIST-CNRS</rights><rights>Copyright © 2011 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.</rights><rights>Copyright Elsevier Limited Aug 30, 2011</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=24472752$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/21867832$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>VAN REES, Johannes B</creatorcontrib><creatorcontrib>DE BIE, Mihaly K</creatorcontrib><creatorcontrib>THIJSSEN, Joep</creatorcontrib><creatorcontrib>BORLEFFS, C. Jan Willem</creatorcontrib><creatorcontrib>SCHALIJ, Martin J</creatorcontrib><creatorcontrib>ERVEN, Lieselot Van</creatorcontrib><title>Implantation-Related Complications of Implantable Cardioverter-Defibrillators and Cardiac Resynchronization Therapy Devices: A Systematic Review of Randomized Clinical Trials</title><title>Journal of the American College of Cardiology</title><addtitle>J Am Coll Cardiol</addtitle><description>The number of implantable cardioverter-defibrillator (ICD) and cardiac resynchronization therapy (CRT) implantations is increasing drastically worldwide, and hence, the number of implanting centers is also increasing. Despite abundant data on the beneficial effect of these devices, little is known regarding safety and complication rates. Eleven ICD and 7 CRT trials were systematically reviewed to provide data on the frequency of in-hospital mortality and complications related to the implantation. Average in-hospital mortality was 2.7% in trials using both thoracotomy and nonthoracotomy ICDs, 0.2% in trials using nonthoracotomy ICDs, and 0.3% in CRT trials. The pneumothorax rate was similar between the nonthoracotomy ICD and CRT trials (0.9%) Coronary sinus complications occurred in 2.0% of patients undergoing CRT. Lead dislodgement rates were higher in CRT trials (5.7%) than in nonthoracotomy ICD trials (1.8%).</description><subject>Biological and medical sciences</subject><subject>Cardiac Resynchronization Therapy Devices</subject><subject>Cardiology</subject><subject>Cardiology. Vascular system</subject><subject>Clinical trials</subject><subject>Defibrillators, Implantable</subject><subject>Dissection</subject><subject>Heart attacks</subject><subject>Hospitals</subject><subject>Humans</subject><subject>Medical sciences</subject><subject>Medicare</subject><subject>Mortality</subject><subject>Ostomy</subject><subject>Postoperative Complications - epidemiology</subject><subject>Prosthesis Implantation - adverse effects</subject><subject>Prosthesis Implantation - mortality</subject><subject>Radiotherapy. Instrumental treatment. Physiotherapy. Reeducation. Rehabilitation, orthophony, crenotherapy. Diet therapy and various other treatments (general aspects)</subject><subject>Randomized Controlled Trials as Topic</subject><subject>Studies</subject><subject>Veins &amp; arteries</subject><issn>0735-1097</issn><issn>1558-3597</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2011</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp90c1q3DAQAGBRGppt2hfooQhKaS92JVmSpdzCpj-BQGC7PRtZGhMttuVK3i2bh-ozVptsKOSQ08DMp9GMhNA7SkpKqPyyKTfG2pIRSksiS0LqF2hBhVBFJXT9Ei1IXYmCEl2fotcpbQghUlH9Cp0yqmStKrZAf6-GqTfjbGYfxmIFvZnB4WXIWW_vkwmHDj-qtge8NNH5sIM4QywuofNt9H0-F2LCZnQPdWPxCtJ-tLcxjP7uvhNe30I00x5fws5bSOf4Av_cpxmGXD74nYc_h9tWuU0Y_N1hkt6PeZAer6M3fXqDTroc4O0xnqFf376ulz-K65vvV8uL62KqCJ0LzrQQlnVGcmXAGWZB6862XFaWtJ1x3Epa0dpZ3naKCy2lM8LVtqtAuLatztCnh75TDL-3kOZm8MlCXnOEsE2NUkJILpjI8vOzkipKs-ZCZfrhCd2EbRzzHg0VXGslNGVZvT-qbTuAa6boBxP3zeOfZfDxCEzKL9NFM1qf_jvOa1YLVv0DRBCrFA</recordid><startdate>20110830</startdate><enddate>20110830</enddate><creator>VAN REES, Johannes B</creator><creator>DE BIE, Mihaly K</creator><creator>THIJSSEN, Joep</creator><creator>BORLEFFS, C. Jan Willem</creator><creator>SCHALIJ, Martin J</creator><creator>ERVEN, Lieselot Van</creator><general>Elsevier</general><general>Elsevier Limited</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7T5</scope><scope>7TK</scope><scope>H94</scope><scope>K9.</scope><scope>NAPCQ</scope><scope>7X8</scope></search><sort><creationdate>20110830</creationdate><title>Implantation-Related Complications of Implantable Cardioverter-Defibrillators and Cardiac Resynchronization Therapy Devices: A Systematic Review of Randomized Clinical Trials</title><author>VAN REES, Johannes B ; DE BIE, Mihaly K ; THIJSSEN, Joep ; BORLEFFS, C. Jan Willem ; SCHALIJ, Martin J ; ERVEN, Lieselot Van</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p301t-42955c2fa648aeda2ce99fcb463c0bfad4c61317dc4bf845966da5d7cf3e5dbb3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2011</creationdate><topic>Biological and medical sciences</topic><topic>Cardiac Resynchronization Therapy Devices</topic><topic>Cardiology</topic><topic>Cardiology. Vascular system</topic><topic>Clinical trials</topic><topic>Defibrillators, Implantable</topic><topic>Dissection</topic><topic>Heart attacks</topic><topic>Hospitals</topic><topic>Humans</topic><topic>Medical sciences</topic><topic>Medicare</topic><topic>Mortality</topic><topic>Ostomy</topic><topic>Postoperative Complications - epidemiology</topic><topic>Prosthesis Implantation - adverse effects</topic><topic>Prosthesis Implantation - mortality</topic><topic>Radiotherapy. Instrumental treatment. Physiotherapy. Reeducation. Rehabilitation, orthophony, crenotherapy. Diet therapy and various other treatments (general aspects)</topic><topic>Randomized Controlled Trials as Topic</topic><topic>Studies</topic><topic>Veins &amp; arteries</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>VAN REES, Johannes B</creatorcontrib><creatorcontrib>DE BIE, Mihaly K</creatorcontrib><creatorcontrib>THIJSSEN, Joep</creatorcontrib><creatorcontrib>BORLEFFS, C. Jan Willem</creatorcontrib><creatorcontrib>SCHALIJ, Martin J</creatorcontrib><creatorcontrib>ERVEN, Lieselot Van</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>Immunology Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of the American College of Cardiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>VAN REES, Johannes B</au><au>DE BIE, Mihaly K</au><au>THIJSSEN, Joep</au><au>BORLEFFS, C. Jan Willem</au><au>SCHALIJ, Martin J</au><au>ERVEN, Lieselot Van</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Implantation-Related Complications of Implantable Cardioverter-Defibrillators and Cardiac Resynchronization Therapy Devices: A Systematic Review of Randomized Clinical Trials</atitle><jtitle>Journal of the American College of Cardiology</jtitle><addtitle>J Am Coll Cardiol</addtitle><date>2011-08-30</date><risdate>2011</risdate><volume>58</volume><issue>10</issue><spage>995</spage><epage>1000</epage><pages>995-1000</pages><issn>0735-1097</issn><eissn>1558-3597</eissn><coden>JACCDI</coden><abstract>The number of implantable cardioverter-defibrillator (ICD) and cardiac resynchronization therapy (CRT) implantations is increasing drastically worldwide, and hence, the number of implanting centers is also increasing. Despite abundant data on the beneficial effect of these devices, little is known regarding safety and complication rates. Eleven ICD and 7 CRT trials were systematically reviewed to provide data on the frequency of in-hospital mortality and complications related to the implantation. Average in-hospital mortality was 2.7% in trials using both thoracotomy and nonthoracotomy ICDs, 0.2% in trials using nonthoracotomy ICDs, and 0.3% in CRT trials. The pneumothorax rate was similar between the nonthoracotomy ICD and CRT trials (0.9%) Coronary sinus complications occurred in 2.0% of patients undergoing CRT. Lead dislodgement rates were higher in CRT trials (5.7%) than in nonthoracotomy ICD trials (1.8%).</abstract><cop>New York, NY</cop><pub>Elsevier</pub><pmid>21867832</pmid><doi>10.1016/j.jacc.2011.06.007</doi><tpages>6</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0735-1097
ispartof Journal of the American College of Cardiology, 2011-08, Vol.58 (10), p.995-1000
issn 0735-1097
1558-3597
language eng
recordid cdi_proquest_miscellaneous_885564525
source MEDLINE; Elsevier ScienceDirect Journals; EZB-FREE-00999 freely available EZB journals; Alma/SFX Local Collection
subjects Biological and medical sciences
Cardiac Resynchronization Therapy Devices
Cardiology
Cardiology. Vascular system
Clinical trials
Defibrillators, Implantable
Dissection
Heart attacks
Hospitals
Humans
Medical sciences
Medicare
Mortality
Ostomy
Postoperative Complications - epidemiology
Prosthesis Implantation - adverse effects
Prosthesis Implantation - mortality
Radiotherapy. Instrumental treatment. Physiotherapy. Reeducation. Rehabilitation, orthophony, crenotherapy. Diet therapy and various other treatments (general aspects)
Randomized Controlled Trials as Topic
Studies
Veins & arteries
title Implantation-Related Complications of Implantable Cardioverter-Defibrillators and Cardiac Resynchronization Therapy Devices: A Systematic Review of Randomized Clinical Trials
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-08T09%3A24%3A54IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Implantation-Related%20Complications%20of%20Implantable%20Cardioverter-Defibrillators%20and%20Cardiac%20Resynchronization%20Therapy%20Devices:%20A%20Systematic%20Review%20of%20Randomized%20Clinical%20Trials&rft.jtitle=Journal%20of%20the%20American%20College%20of%20Cardiology&rft.au=VAN%20REES,%20Johannes%20B&rft.date=2011-08-30&rft.volume=58&rft.issue=10&rft.spage=995&rft.epage=1000&rft.pages=995-1000&rft.issn=0735-1097&rft.eissn=1558-3597&rft.coden=JACCDI&rft_id=info:doi/10.1016/j.jacc.2011.06.007&rft_dat=%3Cproquest_pubme%3E3389146021%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1549985912&rft_id=info:pmid/21867832&rfr_iscdi=true